| Drug Name: | Paromomycin (7542-37-2) |
|---|---|
| PubChem ID: | 165580 |
| SMILES: | C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N |
| InchiKey: | UOZODPSAJZTQNH-LSWIJEOBSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 615.634 |
| LogP | : | -8.8617 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 19 |
| Hydrogen Bond Donor Count | : | 13 |
| Total Polar Surface Area | : | 347.32 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Methotrexate (59-05-2) | Malabsorption Syndrome | Antagonistic | Oral aminoglycosides reduce the activity of the gut flora, which metabolise methotrexate so that more is available for absorption. | Malabsorption due to paromomycin |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category